Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 8, 2025

Synergizing Ferroptosis Suppressor Protein 1 Gene Silencing and Photodynamic Therapy Based on Photosensitive Lipid Nanoparticles for Colon Cancer Immunotherapy.

View Full Paper
Ask AI
Bookmark
Share

Authors

JLJinzhao LiuSumy State UniversityMWMeicen WuUniversity of Hong KongCYChang YangFirst Affiliated Hospital Zhejiang University

Discussion

Loading...

Member takes

Implication

This study reveals the potential of FSP1 gene silencing and lipid nanoparticles in enhancing immunotherapy for colon cancer, suggesting new treatment strategies.

Key Points

  • Ferroptosis suppressor protein 1 gene silencing enhances antitumor immunity in colon cancer cells.
  • Photosensitive lipid nanoparticles effectively deliver siRNA and photodynamic agents for improved immunotherapy.
  • Light activation triggers cell death through ferroptosis and oxidative stress, stimulating immune responses.
  • This approach shows significant antitumor effects in colon cancer models, paving the way for advanced cancer treatments.

Cite This Study

Liu et al. (2025) studied this question.

synapsesocial.com/papers/689dfe97d61984b91e13be6chttps://doi.org/10.1021/acsnano.5c06115
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Integrating mTOR Inhibition and Photodynamic Therapy Based on Carrier‐Free Nanodrugs for Breast Cancer Immunotherapy2024 · 12 citations
  2. 2Recent Advances in Reprogramming Strategy of Tumor Microenvironment for Rejuvenating Photosensitizers‐Mediated Photodynamic Therapy2023 · 57 citations
  3. 3FSP1: a key regulator of ferroptosis2023 · 284 citations
  4. 4Photodynamic Therapy for Colorectal Cancer: A Systematic Review of Clinical Research2022 · 36 citations